NASDAQ Companies

LONDON and RALEIGH, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), […]

Highlights: Lantronix Inc. is collaborating with P3 Digital Services to co-create a pre-integrated hardware and software turnkey In-Vehicle Infotainment (IVI) […]

ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology […]

HANOVER, MD, Jan. 02, 2024 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical […]

RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today […]

NEW YORK and SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company […]

EAGLE, Idaho, Jan. 02, 2024 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant […]

FOSTER CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing […]

Earnings Release Date – Wednesday, February 7, 2024, after 3:30 p.m. Central Time Conference Call Date – Thursday, February 8, […]

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical […]